The overall implication of these MsrA-dependent phenomena is abolishing the expression of biomarkers that are associated with neurodegenerative diseases, such as AD [5,38,39,40] and Parkinson’s disease (PD; through an enhanced ubiquitination of 14-3-3 ζ [6,7,8,14,41]). The gene discussed is MSRA; the disease is Alzheimer disease.